Adolescents’ and Young Adults’ Knowledge and Beliefs About Constituents in Novel Tobacco Products by Wiseman, Kimberly D. et al.
Nicotine & Tobacco Research, 2016, 1581–1587
doi:10.1093/ntr/ntw009
Original investigation
Advance Access publication January 13, 2016
© The Author 2016. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.  
For permissions, please e-mail: journals.permissions@oup.com.
1581
Original investigation
Adolescents’ and Young Adults’ Knowledge and 
Beliefs About Constituents in Novel Tobacco 
Products
Kimberly D. Wiseman MS1, Jennifer Cornacchione PhD1,  
Kimberly G. Wagoner DrPH, MPH1, Seth M. Noar PhD2,4,  
Kathryn E. Moracco PhD3, Randall Teal MA4, Mark Wolfson PhD1,  
Erin L. Sutfin PhD1
1Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC; 2School of 
Media and Journalism, University of North Carolina at Chapel Hill, Chapel Hill, NC; 3Department of Health Behavior, 
Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC; 4Lineberger 
Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
Corresponding Author: Kimberly D. Wiseman, MS, Department of Social Sciences and Health Policy, Wake Forest School 
of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. Telephone: 336-713-1446; Fax: 336-716-7554; 
E-mail: kwiseman@wakehealth.edu
Abstract
Introduction: Novel tobacco products, such as little cigars, cigarillos, hookah, and e-cigarettes, 
and their smoke or aerosol contain chemicals which the FDA has determined to be Harmful or 
Potentially Harmful Constituents. We explored adolescents’ and young adults’ knowledge and 
beliefs about constituents in novel tobacco products and their smoke or aerosol, in order to inform 
risk communication messages.
Methods: Seventy-seven adolescents and young adults (ages 13–25) participated in 10 focus 
groups, including 47 novel tobacco product users and 30 susceptible nonusers. Participants were 
asked to discuss 10 pre-selected constituents found in novel tobacco products and their smoke or 
aerosol. The first author analyzed the discussion for emergent themes.
Results: Participants were generally familiar with arsenic, carbon monoxide, formaldehyde, and 
nicotine, but unfamiliar with acetaldehyde, acrolein, 4-(methylnitrosamino)-1-(3-pyridyl)-1-bu-
tanon (NNK), and N-nitrosonornicotine (NNN). All participants had negative beliefs about most 
constituents, although users had positive beliefs about nicotine. “Unfamiliar” constituents were 
associated with similarly-sounding words (eg, acetaldehyde sounds like acetaminophen), and 
some participants recognized words in the chemical names of NNK/NNN (eg, “nitro”). “Familiar” 
constituents were associated with negative health effects and other common products the constit-
uents are found in. All participants wanted more information about the constituents’ health effects, 
toxicity, and other common products. Most participants were unaware the constituents discussed 
are in novel tobacco products and their smoke or aerosol.
Conclusions: Risk communication messages could capitalize on negative associations with famil-
iar constituents, or attempt to educate about unfamiliar constituents, to discourage novel tobacco 
product use among adolescents and young adults.
Implications: The results of this study have implications for how the FDA and other agencies 
can communicate about the risks of novel tobacco products to the general public, which will be 
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particularly important once the Deeming Rule is finalized. Our findings suggest it may be effective 
to capitalize on the public’s negative beliefs about and associations with familiar constituents, or 
to educate about unfamiliar constituents and their health effects, their concentration and toxicity in 
novel tobacco products and their smoke or aerosol, and other products they are found in.
Introduction
The 2009 Family Smoking Prevention and Tobacco Control Act 
requires tobacco manufacturers to report the levels of constituents 
in tobacco products and tobacco smoke to the FDA.1 In 2012, the 
FDA released a reduced list of 18 Harmful and Potentially Harmful 
Constituents, selected for their representativeness of various chemi-
cal classes and for their established and widely available testing meth-
ods, on which tobacco manufacturers will be required to report.2,3 
While this list applies only to currently regulated tobacco products, 
including cigarettes and cigarette smoke, smokeless tobacco, and 
roll-your-own tobacco, many of the constituents on the reduced list 
are also known to be in novel tobacco products and their smoke 
or aerosol, such as arsenic, carbon monoxide, and formaldehyde.4–8 
Some novel tobacco products and their smoke, like little cigars, 
cigarillos, and hookah, often contain similar levels of constituents 
as cigarettes.4–8 While e-cigarettes and e-cigarette aerosol generally 
contain lower levels of and fewer constituents than other tobacco 
products,4,5 the effects of repeated, long-term exposure to low levels 
of many constituents are still unknown.
In April of 2014, the FDA issued a proposed rule to extend its 
regulatory authority to any product meeting the statutory definition 
of a “tobacco product,” which would include novel tobacco prod-
ucts such as little cigars and cigarillos, hookah, and e-cigarettes.9 As 
part of this Deeming Rule, tobacco manufacturers will be required to 
disclose the quantities of constituents in novel tobacco products and 
their smoke or aerosol in the same manner as traditional tobacco 
products, and the FDA will be tasked with communicating this infor-
mation to the public in “a format that is understandable and not 
misleading to a lay person.”1,9 In order to best use this information to 
communicate with the public about the risks of novel tobacco prod-
ucts, the FDA will need a better understanding of public knowledge 
and beliefs about constituents in these products.
Little research has explored what the public knows and believes 
about harmful constituents in tobacco products and tobacco 
smoke. A  study by Hall and colleagues10 found that among US 
adult smokers and nonsmokers ages 18 and above, awareness 
of a majority of constituents was very low. Constituents which 
were familiar to a majority of the participants, such as arsenic, 
carbon monoxide, and ammonia, were also the constituents which 
elicited the most worry and produced the greatest discourage-
ment from wanting to smoke. Similarly, analysis of data from the 
International Tobacco Control Four Country Survey (ITC-4) has 
shown that across Canada, Australia, the United States, and the 
United Kingdom, smokers were mostly aware that tobacco smoke 
contains carbon monoxide, but were less aware that it contains 
arsenic, cyanide, and mercury.11,12
Even less research has examined the public’s knowledge and 
beliefs about constituents in novel tobacco products and their smoke 
or aerosol. One recent study by Sanders-Jackson and colleagues13 
presented US young adults with the statement “E-cigarettes do not 
contain any of the toxic chemicals that can be found in combustible 
cigarettes” and asked them to indicate whether the statement was 
true or false. Nearly 32% of young adults incorrectly answered that 
the statement was true, and almost half (48%) responded “don’t 
know,” while only 20% of young adults correctly answered that the 
statement was false.13
Data from the 2014 National Youth Tobacco Survey14 showed 
high rates of use of each of these products among high school stu-
dents across the nation; in the past 30 days, 8.2% had smoked a 
cigar product, 9.4% had smoked hookah, and 13.4% had used an 
e-cigarette. Similarly high rates were found for young adults; data 
from the 2012–2013 National Adult Tobacco Survey15 showed that 
in the past 30 days, 8.9% had smoked a cigar product, 18.2% had 
smoked hookah, and 8.3% had used an e-cigarette. Given the high 
rates of novel tobacco product use among adolescents and young 
adults, and the widespread lack of knowledge about the constitu-
ents present in novel tobacco products and their smoke or aerosol, 
the purpose of this study was to acquire more information about 
adolescent and young adults’ knowledge and beliefs about harmful 
constituents found in novel tobacco products and their smoke or 
aerosol. We employed a qualitative approach to address three spe-
cific research questions: (1) What do adolescents and young adults 
know about or associate with constituents? (2) What do adolescents 
and young adults want to know about the constituents in novel 
tobacco products? (3) What do adolescents and young adults think 
about the constituents being in novel tobacco products?
Methods
Ten focus groups were conducted in and around Chapel Hill, North 
Carolina from February to April 2014 as formative work for a larger 
study to develop effective risk communication messages to inform 
adolescents and young adults about the risks of using novel tobacco 
products.
Participants
We recruited adolescent (ages 13–17) and young adult (ages 18–25) 
focus group participants using purposive sampling methods across 
the Triangle region of North Carolina. Participants were recruited 
through a variety of methods, including in-person recruitment, 
emails to various listservs, Craigslist advertisements, advertisements 
in college and local newspapers, and radio and TV spots. In per-
son recruitment was conducted at tobacco retail outlets, recreation 
centers, bars, coffee shops, colleges, and high schools. Recruitment 
materials encouraged individuals to visit a recruitment website and 
complete an eligibility screener. Respondents who reported any 
novel tobacco product use (including electronic cigarettes, hookah, 
cigarillos, cigars, or smokeless tobacco) in the past 30  days were 
categorized as “users” and were considered eligible for the focus 
groups. Respondents who reported they were willing to try any novel 
tobacco products, based on items adapted from Pierce’s Susceptibility 
to Smoking measure16,17 were categorized as “susceptible nonusers’ 
and were considered eligible for the focus groups, given that suscep-
tibility to using tobacco products has been shown to predict future 
use of tobacco products.17–19 Respondents who were unwilling to 
try any novel tobacco products were categorized as “nonsusceptible 
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nonusers” and were excluded from the focus groups, since nonusers 
are typically not targets for risk communication campaigns. Eligible 
respondents were invited to participate in one of 10 focus groups, 
stratified by age (adolescents or young adults) and novel tobacco 
product use status (users or susceptible nonusers). Target enroll-
ment for each focus group was approximately 7–10 participants, 
with a total target enrollment of 42–60 users and 28–40 susceptible 
nonusers.
Procedure
Prior to each focus group, participants provided written informed 
consent (young adults) or assent (adolescents). Parents of adoles-
cent participants were sent an informational letter about the study 
prior to the focus group, and given the opportunity to respond 
within 5  days if they did not want their child to participate. The 
Institutional Review Board at Wake Forest School of Medicine 
approved this study. Additional privacy protection was secured by 
the issuance of a Certificate of Confidentiality by the Department of 
Health and Human Services.
The focus groups lasted approximately 90 minutes and were 
facilitated by a three-person team, including a moderator, co-mod-
erator and note taker. The moderators were MA and PhD-level 
qualitative research specialists with more than 15 years of experi-
ence conducting focus groups with young adults and adolescents. 
A semi-structured interview guide (Table 1) was used to facilitate 
discussion in all groups, and probes were used as necessary to clar-
ify and evoke additional detail. The interview guide was developed 
based on a literature review and prior pilot work, and focused 
on generating discussion around the three a priori research ques-
tions noted above. To address these research questions, partici-
pants were asked about 10 constituents from FDA’s reduced list 
of Harmful and Potentially Harmful Constituents, including acet-
aldehyde, acrolein, arsenic, benzene, cadmium, carbon monoxide, 
formaldehyde, nicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanon (NNK), and N-nitrosonornicotine (NNN). We selected 
these constituents because they have been found to be present in 
novel tobacco products.4–8 Participants were shown a list of these 
constituents and asked whether they had heard of or knew any-
thing about each constituent. Participants were also asked what 
they would like to know about these constituents. Finally, partici-
pants were shown and asked to respond to additional lists indicat-
ing which of the 10 constituents are found in each novel tobacco 
product (little cigars and cigarillos, hookah, and e-cigarettes) and 
its smoke or aerosol.
At the conclusion of each focus group, we provided participants 
with a handout of information about novel tobacco products, includ-
ing constituents found in these products. The handout was adapted 
from similar information sheets from the Campaign for Tobacco-
Free Kids, the American Lung Association, the American Cancer 
Society, and the National Cancer Institute. Participants received a 
$50 Amazon gift card for their participation.
Analysis
The primary aim of our focus groups was descriptive and focused 
on understanding participant’s knowledge and beliefs about con-
stituents found in novel tobacco products and their smoke or aer-
osol. Thus, our analytic approach was similar to grounded theory 
methods,20,21 in that the findings are “grounded” in the data and 
were developed inductively and in constant interaction with the 
data. Although we identified a priori research questions, we did not 
develop or test specific hypotheses.
Focus groups were digitally recorded and transcribed verbatim 
by an independent transcriptionist. Using the semi-structured inter-
view guide, codes were developed for each question in the interview 
guide which addressed an a priori research question (eg, a “more 
information” code was applied to each group’s discussion of addi-
tional information they would like to know about the constituents 
[Research Question #2]). The codebook was piloted by the authors 
using two randomly selected transcripts, and adjustments were 
made to create the final codebook. Two pairs of coders used the final 
codebook to independently code five out of the 10 transcripts using 
Atlas.ti 7.0, a qualitative data analysis software program. After the 
initial round of coding, the coders met and discussed discrepancies 
to ensure consistent application of codes. Once discrepancies were 
resolved, the codes were merged into a master file for data analy-
sis. The first author reviewed the codes and conducted interpreta-
tive analysis to identify emergent and recurrent themes related to 
the research questions. The first author created written summaries of 
themes related to each research question, and met with co-authors to 
discuss and synthesize themes across age groups and novel tobacco 
product user status.
Results
Overall, findings were consistent across focus groups (adolescents 
and young adults, and novel tobacco product users and nonusers), 
with only a few differences noted below.
Participant Characteristics
A total of 77 individuals (27.3% adolescents [N = 21] and 73.7% 
young adults [N = 56]; 61.0% users [N = 47] and 39.0% susceptible 
nonusers [N = 30]) participated in the focus groups. See Table 2 for 
participant characteristics by age group and novel tobacco product 
use status (herein referred to as “users” and “nonusers”). Across all 
10 focus groups, the majority of participants were Non-Hispanic 
(91%), and white (57%) or black (26%). Just over half the partici-
pants were female (56%). The mean age of adolescent participants 
was 15.8 years old, and the mean age of young adult participants 
was 20.5 years old.
Constituent Knowledge
Participants had varying levels of knowledge about the constituents. 
Almost all participants were familiar with arsenic, carbon monoxide, 
Table 1. Focus Group Semi-Structured Interview Guide
Research question Domain Interview guide questions
#1 Knowledge Which chemicals have you heard of?
What do you know about or associate with [constituent]?
#2 Desired knowledge What would you like to know about these chemicals?
#3 Constituents in novel tobacco products What do you think about these chemicals being in [product smoke or aerosol]?
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formaldehyde, and nicotine. Some participants were familiar with 
benzene and cadmium, with young adults being more likely than 
adolescents to have heard of these constituents. Almost no partici-
pants were familiar with acetaldehyde, acrolein, NNK, or NNN.
Table  3 describes participant’s knowledge about specific con-
stituents. Knowledge about arsenic, carbon monoxide, formalde-
hyde, and nicotine was fairly similar between adolescents and young 
adults, with most participants knowing basic information about 
these constituents, such as that they are harmful chemicals and are 
often found in other products. For example, most participants knew 
arsenic is used as a poison. One young adult nonuser said, “I think 
it’s [arsenic] a poison that has been used to silently poison people 
over time. Like wives that hate their husbands cook arsenic into their 
food and then they’ll just slowly get weaker and weaker and eventu-
ally die.” All participants also knew that nicotine is addictive and can 
make you sick in high doses; however, there was confusion about 
exactly how nicotine affects the body. For example, one young adult 
nonuser said, “I know what nicotine is, but I don’t honestly know 
that much about it.”
Discussion revealed that participants had varying sources of 
knowledge about these constituents. Many participants attributed 
their familiarity with certain constituents, such as benzene and for-
maldehyde, to taking chemistry in high school. One young adult 
nonuser said, “I remember it [formaldehyde] in chemistry class, but 
I don’t remember what we did with it. I remember it smelled bad.” 
Others attributed their knowledge of certain constituents to their 
portrayal in popular media. For example, some participants knew 
arsenic is a poison because it is commonly used in movies and TV 
shows. One adolescent nonuser said, “Maybe because I watched a 
whole bunch of crime shows, but people poison each other, trying 
to kill their spouse.”
Beliefs About Constituents
In general, participants had negative beliefs about most of the con-
stituents. Almost all participants were worried about the health 
effects of the constituents, and tended to assume a constituent had 
negative health effects, even if they didn’t know what it was. One 
young adult user said, “Because all these look like chemicals or tox-
ins and something that’s poisonous; that’s not good for you.” Many 
participants believed the constituents sounded artificial, and many 
said the constituents sounded dangerous. For example, one young 
adult user said, “Normally, from what I’ve learned in science, any-
thing that ends with ‘hyde’ or ‘ide’ would kind of throw up red flags, 
I can say, as far as health reasons.”
Nicotine differed from the other constituents, with users and 
nonusers having different beliefs. Nonusers typically had negative 
beliefs about nicotine; they were worried about nicotine and the fact 
that it can lead to addiction. One adolescent nonuser said, “So that’s 
[nicotine] also a concern because there’s a risk of dependence.” On 
the other hand, users typically had positive beliefs about nicotine; 
they mentioned that nicotine is a good stress reliever and it boosts 
concentration. For example, one young adult user said, “…I feel 
like nicotine, I don’t know, it helps me concentrate a lot. Like if I’m 
stressed out, it’s a good de-stresser….”
Most participants tended to associate familiar constituents with 
common products or uses. For example, the majority of participants 
associated arsenic with rat poison, carbon monoxide with car exhaust, 
and formaldehyde with embalming fluid. These associations typically 
induced negative reactions from participants, as they imagined ingest-
ing the common product while using novel tobacco products. For 
example, one young adult user said of cadmium, “I feel like I don’t 
want it [a metal] in my body.” Participants were generally in agree-
ment that familiar constituents were particularly worrisome, due to 
these negative associations with other common products. For exam-
ple, one young adult user said they would worry about arsenic and 
carbon monoxide “… because they’re both so closely connected to 
death.”
Table 3. Participants’ Knowledge about Familiar Constituents
Constituent Participants’ Knowledge
Arsenic Poison
Can kill you
Used in movies/TV shows to murder people
Found in foods in small amounts
Carbon Monoxide Colorless and odorless gas
Comes from car exhaust
Detectors in homes
People kill themselves in garages
Known as the “silent killer”
Formaldehyde Preserves dead things
Very strong odor
Nicotine Addictive
Can make you sick in high doses
Alters brain chemistry
Uncertainty about how it affects the body
Benzene Chemical in gasoline
Cadmium An element
A heavy metal
Table 2. Demographic Information by Novel Tobacco Product Use and Age Group
Total (N = 77)
Novel tobacco product use Age group
Susceptible nonusers (N = 30) Users (N = 47) Adolescents (N = 21) Young adults (N = 56)
Mean age 19.2 18.9 19.4 15.8 20.5
Gender
 Female 43 (56%) 18 (60%) 25 (53.2%) 12 (57.1%) 31 (55.4%)
 Male 34 (44%) 12 (40%) 22 (46.8%) 9 (42.9%) 25 (44.6%)
Ethnicity
 Non-Hispanic 70 (91%) 28 (93.3%) 42 (89.4%) 20 (95.2%) 50 (89.3%)
 Hispanic 7 (9%) 2 (6.7%) 5 (10.6%) 1 (4.8%) 6 (10.7%)
Race
 White 44 (57%) 18 (60%) 25 (53.2%) 14 (66.7%) 29 (51.8%)
 Black 20 (26%) 6 (20%) 14 (29.8%) 0 (0%) 20 (35.7%)
 Other 13 (17%) 6 (20%) 8 (17%) 7 (33.3%) 7 (12.5%)
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When participants had not previously heard of a constituent, or 
had heard of it but knew nothing about it, they tended to associ-
ate the constituent with similarly sounding words. For example, one 
young adult participant said of acetaldehyde, “It makes me think of 
acetaminophen because it starts the same way.” This type of associa-
tion was typically negative, although adolescents had positive asso-
ciations with cadmium because it sounded like things with which 
they had positive associations. For example, one adolescent nonuser 
said, “It just doesn’t sound bad. Isn’t there a chocolate company 
that’s like… Cadbury?” This pattern held true for all the constituents 
except NNK and NNN. For these constituents, participants noticed 
words they recognized within the chemical name, such as “amino,” 
“meth,” and “nicotine.” Participants disagreed about whether they 
were worried about a constituent they had never heard of before. 
Some participants were concerned by not knowing what a con-
stituent was. For example, one adolescent nonuser said, “It looks 
more familiar, but I still don’t know what it is. Therefore, it’s scary.” 
Others were less worried by not knowing what a constituent was. 
One young adult user said, “I’m completely neutral. I have no idea 
what this stuff is.”
Desired Knowledge
Almost all participants wanted to know about the health effects of 
the constituents. Most participants assumed the constituents were 
dangerous, but wanted to be able to link specific constituents to spe-
cific health problems. For example, one adolescent user said, “I want 
to know what each one does to your body, specifically.”
Almost all participants were also interested in knowing the con-
centrations of the constituents within novel tobacco products and 
their smoke or aerosol. Many believed product packaging should 
display concentration information for the constituents, and one par-
ticipant suggested a “chemical nutrition label.” Some users indicated 
they might switch to brands that have lesser concentration of certain 
constituents. For example, one young adult user said, “I’d also like to 
know which brands carry more of which chemicals.”
Along with concentration, most participants were interested in 
understanding the toxicity of the constituents. Several participants 
knew that the FDA and other agencies deem safe thresholds for con-
stituents and wanted to know how close the concentrations in novel 
tobacco products and their smoke or aerosol come to those thresh-
olds. For example, one young adult nonuser said, “What amount is 
in the product? Just like with arsenic, there’s a toxic level. So how 
close to the toxic level are you talking?”
Additionally, most participants expressed interest in learning 
other common uses for the constituents. Some participants expressed 
that they knew common uses for some of the constituents such as 
arsenic being in rat poison, but that they would also want this infor-
mation for other constituents. One young adult nonuser said, “Like 
maybe common uses of them… like formaldehyde, we know that’s 
used for storage of dead animals and stuff like that.”
Constituents in Novel Tobacco Products
Overall, participants were aware novel tobacco products and their 
smoke or aerosol contain a variety of chemicals, but were surprised 
to learn which particular constituents were in the products and their 
smoke or aerosol. For example, one young adult nonuser said, “It’s 
kinda surprising to me that all these chemicals are in hookah smoke.” 
One adolescent user said, “I just thought there were a couple [chemi-
cals], not several.” A few participants indicated they were surprised 
to learn that novel tobacco products and their smoke or aerosol 
contain these constituents because they believed novel tobacco prod-
ucts are healthier than cigarettes. For example, one adolescent user 
discussed how they thought little cigars were more natural than 
cigarettes “because they’re wrapped in the leaf… and the stuff inside 
just looks more earthy than cigarettes.” Almost all participants were 
also surprised to learn that novel tobacco products and their smoke 
or aerosol contain these constituents because they are not currently 
disclosed on product packaging. For example, one young adult user 
expressed frustration, saying, “Because they give you the Surgeon 
General’s warning that says you may get cancer, but they don’t say 
‘oh, by the way, there’s ammonia in there, a little bit of benzene.’”
Discouragement
Many participants, both users and nonusers, indicated that learning 
these constituents are in novel tobacco products and their smoke 
or aerosol would discourage them from using or trying the prod-
ucts. One young adult user said, “This list actually makes me feel 
less good about hookah. It definitely pauses me for a second to take 
a look at something closer.” One adolescent nonuser said, “It kind 
of lets me know that hookah is probably just as bad as smoking a 
cigarette. Because when I read that, I didn’t believe it. But now it’s 
like – oh, that looks pretty bad.”
However, other participants indicated their opinions would 
depend on the amount of the constituents in the novel tobacco prod-
ucts. For example, some participants understood that constituents 
may not be harmful in low doses which are below safety thresholds. 
One adolescent nonuser said, “But there can’t be that much arsenic 
in hookah smoke to be a major concern. Because there’s arsenic in 
water. But it’s such low concentrations that it doesn’t really harm 
you.”
Discussion
The current study yielded several insights about adolescents’ and 
young adults’ knowledge and beliefs about harmful constituents 
in novel tobacco products and their smoke or aerosol. Evidence 
from previous quantitative work10–12 has shown that adult smokers 
and nonsmokers are familiar with some constituents, such as arse-
nic, carbon monoxide, and ammonia, but unfamiliar with others. 
Our findings show that adolescents and young adults, both novel 
tobacco product users and nonusers, also report similar aware-
ness of constituents. Our work adds to the existing literature by 
highlighting that adolescents and young adults tend to make asso-
ciations between known constituents and their health effects and 
other common products, and between unknown constituents and 
similarly-sounding words (or recognize words within the chemical 
names of the constituents). Participants in our study held mostly 
negative beliefs about constituents, except for nicotine. Novel 
tobacco product users in particular held positive beliefs about nico-
tine and discussed its positive benefits, which has also been found in 
other qualitative work.22
The current work also reveals that adolescents and young adults 
are generally unaware that these constituents are found in novel 
tobacco products and their smoke or aerosol, which confirms pre-
vious work by Sanders-Jackson and colleagues,13 who found that 
young adults were unaware that e-cigarettes contain some of the 
same chemicals found in cigarettes. Our findings indicate that 
this may be due to misperceptions about the relative risk of novel 
tobacco products, and the fact that novel tobacco products typically 
do not have product warnings or disclosures.
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Additionally, previous work10 has demonstrated that constituents 
which were familiar to a majority of adults were also the constituents 
which elicited the most worry and produced the greatest discourage-
ment from wanting to smoke cigarettes. Our findings indicate that 
adolescents and young adults may be divided on whether known 
constituents elicit discouragement from using novel tobacco prod-
ucts. For example, while some participants were discouraged by 
known constituents such as arsenic, others indicated their opinions 
would depend on the concentrations of the constituents, because 
they were aware that some constituents may not be harmful in low 
doses which are below safety thresholds. This is an area that future 
research needs to address both with quantitative and qualitative 
research.
Implications
The results of this study have implications for how the FDA and 
other agencies can communicate about the risks of novel tobacco 
products to the general public, which will be particularly important 
once the Deeming Rule is finalized. Risk communication campaigns 
are effective when formative research occurs to identify the intended 
audiences’ general understanding of the issue.23 The current work 
provides formative data to help create campaigns by understanding 
what people know about harmful constituents, as well as what they 
want to know. Providing this novel information to the public will 
help increase campaign effectiveness because campaigns that pre-
sent new information are generally more effective than campaigns 
that provide similar information that is already known.24 Our find-
ings suggest it may be effective to capitalize on the public’s negative 
beliefs about and associations with familiar constituents. For exam-
ple, participants in our study knew arsenic is found in rat poison 
and is used to kill people. Participants indicated that these types of 
associations would discourage them from using novel tobacco prod-
ucts, and risk messages about novel tobacco products could attempt 
to make these associations very salient.
Our findings also suggest it may be effective to message about 
constituents which are unfamiliar to the public. Constituents such as 
NNN and NNK were particularly worrisome to participants, espe-
cially when they were shown the long, complex chemical name. Many 
participants expressed that not knowing anything about these con-
stituents would discourage them from using novel tobacco products. 
Others who were less discouraged by the constituents themselves 
wanted to know additional information about the constituents, such 
as their health effects, their concentration and toxicity, and other 
products they are found in. Risk messaging campaigns could explore 
how best to educate the public about these unfamiliar constituents 
and what type of information is most effective in discouraging novel 
tobacco product use.
Additionally, our findings reveal that adolescents and young adults 
do want more information about the constituents in novel tobacco 
products and their smoke or aerosol. The FDA and other agencies 
have an opportunity to educate the public about these constituents, 
but should be careful about how they share information about these 
constituents. Traditionally, the tobacco industry communicated con-
stituent information to the public through the reporting of emission 
levels for specific constituents, like tar, nicotine, and carbon monoxide, 
on the side of cigarette packaging (eg, “10 mg Tar, 0.9 mg Nicotine, 
10 mg Carbon Monoxide”). Previous research has shown that quan-
titative emission labels are often misinterpreted by the public and are 
used to justify brand switching in order to mitigate risk.25–27 For exam-
ple, although constituent quantities do not directly relate to a tobacco 
products’ risk, research has shown that consumers generally equate 
lower levels of constituents with lower levels of risk.25–27 Indeed, par-
ticipants in the current study exhibited the same misinterpretation, 
saying they would like to see “chemical nutrition labels” and would 
switch to brands which contain less of a certain constituent.
Although quantitative emissions labels are popularly endorsed 
by the public, research has shown that descriptive warnings can be 
more effective for communicating about harmful constituents. For 
example, Australia has implemented descriptive statements on ciga-
rette packs such as “Smoking exposes you to more than 40 harmful 
chemicals.” Hammond and White28 found that adults, both smok-
ers and nonsmokers, rated descriptive statement packaging as easier 
to understand than quantitative emission packaging, and that the 
descriptive statement packaging was less likely to be used to com-
pare brands to make incorrect assumptions about risk. This suggests 
that in order to develop risk messaging campaigns and to publicly 
display constituent information to the public in “a format that is 
understandable and not misleading to a lay person,”1,9 the FDA and 
other agencies should consider taking a communication approach 
which is more descriptive, rather than quantitative.
Limitations
Because qualitative research emphasizes depth rather than breadth, 
our relatively small convenience sample prohibits us from general-
izing our findings to all adolescents and young adults. Qualitative 
research also involves subjectivity and an element of expert judg-
ment. Nevertheless, our study was strengthened by our use of several 
qualitative research strategies to mitigate subjectivity and increase the 
dependability and validity of our study results. For example, our focus 
groups were conducted by experienced moderators using a standard-
ized interview guide, and were coded by two independent coders who 
coded the transcripts using a standardized codebook and a protocol 
for resolving coding differences. Additionally, the first author met with 
the co-authors to discuss and synthesize emergent themes.
The current study was also limited by the state of the science 
about constituents in novel tobacco products and their smoke or 
aerosol, which was relatively sparse at the time we conducted the 
focus groups and limited the particular constituents we were able 
to discuss with our participants. Since the focus groups were con-
ducted, new research has continued to expand the list of constituents 
found in novel tobacco products and their smoke or aerosol, espe-
cially for e-cigarettes.4,5
Conclusions
The current research provides a rich descriptive understanding of 
what adolescents and young adults know and believe about constitu-
ents found in novel tobacco products and their smoke or aerosol, 
and has implications for the development of risk messaging cam-
paigns by agencies such as the FDA. Future research studies should 
continue to assess knowledge and beliefs about constituents with 
quantitative and qualitative studies, and also begin to test specific 
risk messages about harmful constituents in both experimental and 
real-world settings.
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